Topic Review
Nanoparticle Features That Impact Liver-Targeting and Tolerogenic Effects
Liver-targeting nanoparticles have emerged as a promising platform for the induction of immune tolerance by taking advantage of the liver’s unique tolerogenic properties and nanoparticles’ physicochemical flexibility. Such an approach provides a versatile solution to the treatment of a diversity of immunologic diseases.
  • 331
  • 05 Jan 2024
Topic Review
Basis for Treatment of  Patent Ductus Arteriosus
Ductus arteriosus (DA) serves a crucial role in utero by redirecting the oxygenated blood away from the fluid-filled fetal lungs, and towards the systemic circulation for optimal fetal development. Typically, in term infants, DA undergoes functional constriction and closure within 1–3 days after birth, followed by tissue remodeling to ensure permanent closure. However, the DA may remain persistently patent postnatally, especially in very preterm infants, and is commonly referred to as patent ductus arteriosus (PDA). Its prevalence is inversely proportional to gestational age; more than 60% of preterm infants under 28 weeks of gestational age (GA) continue to have PDA 7 days after birth or longer. 
  • 115
  • 05 Jan 2024
Topic Review
Radiomics Facilitating the Treatment of Malignant Liver Tumors
In the realm of managing malignant liver tumors, the convergence of radiomics and machine learning has redefined the landscape of medical practice. The field of radiomics employs advanced algorithms to extract thousands of quantitative features (including intensity, texture, and structure) from medical images. Machine learning, including its subset deep learning, aids in the comprehensive analysis and integration of these features from diverse image sources. The fusion of radiomics and machine learning has yielded promising results in the evaluation of treatments for malignant liver tumors (e.g., surgical resection, liver transplant, ablation therapy, transarterial chemoembolization (TACE), radiotherapy, and systemic therapy.
  • 117
  • 05 Jan 2024
Topic Review
Stroke in Patients with Atrial Fibrillation
Atrial fibrillation (AF) is the most common sustained arrythmia and one of the strongest risk factors and causal mechanisms of ischemic stroke (IS). Acute IS due to AF tends to be more severe than with other etiology of IS and patients with treated AF have reported to experience worse outcomes after endovascular treatment compared with patients without AF. As cardioembolism accounts for more than a fifth of ISs and the risk of future stroke can be mitigated with effective anticoagulation, which has been shown to be effective and safe in patients with paroxysmal or sustained AF, the screening of patients with cryptogenic IS (CIS) for AF is paramount.
  • 344
  • 05 Jan 2024
Topic Review
Hyperhomocysteinemia in Adult Patients
Hyperhomocysteinemia (HHcy) is a metabolic condition characterized by elevated blood homocysteine (Hcy) levels, which is implicated in various disorders, serving as a potential risk factor for serious complications.
  • 118
  • 05 Jan 2024
Topic Review
The NRF2 Pathway Regulates Cellular Responses to Stress
Nuclear factor erythroid 2-related factor (NRF2) belongs to the cap “n” collar (CNC) family of transcription factors and is found in the cytoplasm of non-stressed cells in a combined form with KEAP1. Oxidative stress activates the transcription factor NRF2, which plays a key role in alleviating redox-induced cellular injury.
  • 116
  • 05 Jan 2024
Topic Review
Dersimelagon in the Treatment of Erythropoietic Protoporphyria
Erythropoietic protoporphyria (EPP) is a genetic disorder stemming from reduced ferrochelatase expression, the final enzyme in the pathway of heme biosynthesis. A closely related condition, X-linked protoporphyria (XLP), bears similar clinical features although it arises from the heightened activity of δ-aminolevulinic acid synthase 2 (ALAS2), the first and normally rate-controlling enzyme in heme biosynthesis in developing red blood cells. Both of these abnormalities result in the buildup of protoporphyrin IX, leading to excruciating light sensitivity and, in a minority of cases, potentially fatal liver complications. Traditionally, managing EPP and XLP involved sun avoidance. However, the emergence of innovative therapies, such as dersimelagon, is reshaping the therapeutic landscape for these conditions.
  • 382
  • 05 Jan 2024
Topic Review
COVID-19 on Oral Health
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and transmission are generally known to be produced by respiratory droplets and aerosols from the oral cavity (O.C.) of infected subjects, as stated by the World Health Organization. Saliva also retains the viral particles and aids in the spread of COVID-19. 
  • 97
  • 05 Jan 2024
Topic Review
Pharmacomicrobiomics and Drug–Infection Interactions
Microorganisms have a close relationship with humans, whether it is commensal, symbiotic, or pathogenic. It has been documented that microorganisms may influence the response to drug therapy. Pharmacomicrobiomics is an emerging field that focuses on the study of how variations in the microbiome affect the disposition, action, and toxicity of drugs. Two additional sciences have been added to complement pharmacomicrobiomics, namely toxicomicrobiomics, which explores how the microbiome influences drug metabolism and toxicity, and pharmacoecology, which refers to modifications in the microbiome as a result of drug administration. Additionally, the concept of "drug-infection interaction" is included to describe the influence of pathogenic microorganisms on drug response. This entry analyzes in detail each of these concepts.
  • 454
  • 05 Jan 2024
Topic Review
Vitamin D with Ovarian Reserve Markers and Depression
Since the identification of vitamin D receptors in both the female reproductive tract and the central nervous system, further data have shown that vitamin D is involved in the processes of reproductive and mental health.
  • 140
  • 05 Jan 2024
  • Page
  • of
  • 1352
Video Production Service